Combining the downregulation of FBXL5 in pancreatic cancer samples and its positive correlation with survival, our results indicate that FBXL5, as a downstream target of ALKBH5, plays a vital role in protecting against pancreatic cancer. This evidence concerns the gene FBXL5 and pancreatic neoplasm.